PolyNovo Limited (ASX:PNV)

Market Cap	873.92M
Revenue (ttm)	128.70M
Net Income (ttm)	13.21M
Shares Out	690.84M
EPS (ttm)	0.02
PE Ratio	66.93
Forward PE	55.12
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,902,774
Average Volume	2,484,902
Open	1.405
Previous Close	1.405
Day's Range	1.265 - 1.405
52-Week Range	0.930 - 2.400
Beta	1.57
RSI	37.09
Earnings Date	Nov 24, 2025

About PolyNovo

PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; Beta Cell implant, a novel intracutaneous ectopic pancreas to tre...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 301
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: PNV

Financial Performance

In 2025, PolyNovo's revenue was 128.70 million, an increase of 24.67% compared to the previous year's 103.23 million. Earnings were 13.21 million, an increase of 151.17%.